<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="uz">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">research-focus</journal-id>
      <journal-title-group>
        <journal-title>Research Focus International Scientific Journal</journal-title>
        <abbrev-journal-title abbrev-type="publisher">Research Focus</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub" publication-format="electronic">2181-3833</issn>
      <publisher>
        <publisher-name>Ilm-fan va innovatsiyalar akademiyasi</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.66073/refocus.v5i9.0902</article-id>
      <article-id pub-id-type="other" assigning-authority="relibrary.uz">REL-A-014133</article-id>
      <article-categories>
        <subj-group subj-group-type="oak">
          <subject>14.00.00</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title xml:lang="uz">Turli gormonal faollikka ega gipofiz makroadenomalarining MRT asosidagi morfologik tahlili va o‘sish xususiyatlari</article-title>
        <trans-title-group xml:lang="en">
          <trans-title>MRI-based morphological analysis and growth patterns of pituitary macroadenomas with different hormonal activity</trans-title>
        </trans-title-group>
        <trans-title-group xml:lang="ru">
          <trans-title>Морфологический анализ и особенности роста макроаденом гипофиза с различной гормональной активностью на основе МРТ</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group content-type="author">
        <contrib contrib-type="author">
          <name>
            <surname>MUHAMMADOV</surname>
            <given-names>Nuriddin Asqarovich</given-names>
          </name>
          <aff>Samarqand davlat tibbiyot universiteti huzuridagi Neyroxirurgiya va neyroreabilitatsiya ixtisoslashtirilgan ilmiy-amaliy markazi, Samarqand, O‘zbekiston</aff>
        </contrib>
      </contrib-group>
      <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-10-05">
        <day>05</day>
        <month>10</month>
        <year>2026</year>
      </pub-date>
      <pub-date date-type="collection">
        <year>2026</year>
      </pub-date>
      <volume>5</volume>
      <issue>9</issue>
      <fpage>24</fpage>
      <lpage>32</lpage>
      <permissions>
        <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
          <ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>Ushbu asar Creative Commons Attribution 4.0 International litsenziyasi asosida litsenziyalangan.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="https://relibrary.uz/REL-A-014133/"/>
      <abstract xml:lang="uz">
        <p>Dolzarblik. Gipofiz makroadenomalari sellar-parasellyar sohaning eng muhim hajmli hosilalari qatoriga kiradi. Ularning klinik kechishi nafaqat o‘lchamiga, balki gormonal faolligi, o‘sish yo‘nalishi, kavernoz sinusga invaziyasi, suprasellyar kengayishi va optik xiazma bilan munosabatiga ham bog‘liq. Magnit-rezonans tomografiya gipofiz makroadenomalarini aniqlash, ularning topografik-anatomik tarqalishini baholash va jarrohlik taktikasini rejalashtirishda asosiy diagnostik usul hisoblanadi. Material va usullar. Maqolada gipofiz makroadenomalarini baholash uchun MRT-morfologik tahlil algoritmi ishlab chiqildi. Baholash mezonlari sifatida o‘sma o‘lchami, hajmi, suprasellyar va parasellyar kengayishi, Knosp darajasi, optik xiazma kompressiyasi, gipofiz oyoqchasi deviatsiyasi, nekroz, kista, gemorragik o‘zgarishlar va sfenoidal sinus bilan munosabat tahlil qilindi. Natijalar. Gormonal faol va nofaol makroadenomalar o‘sish yo‘nalishi va invazivlik darajasi bo‘yicha farqlanishi mumkin. Prolaktinomalar va somatotropinomalar ayrim holatlarda kavernoz sinusga lateral invaziya, nofaol makroadenomalar esa ko‘proq suprasellyar kengayish va optik xiazma kompressiyasi bilan namoyon bo‘ladi. Xulosa. MRT asosidagi morfologik tahlil gipofiz makroadenomalarining biologik xatti-harakati, operatsion xavfi va davolash taktikasini individual belgilashda muhim ahamiyatga ega.</p>
      </abstract>
      <trans-abstract xml:lang="en">
        <p>Relevance. Pituitary macroadenomas are clinically significant mass lesions of the sellar and parasellar region. Their clinical course is determined not only by tumor size but also by hormonal activity, growth direction, cavernous sinus invasion, suprasellar extension, and anatomical relationship with the optic chiasm. Magnetic resonance imaging is the main instrumental diagnostic method for evaluating the morphological structure, topographic-anatomical characteristics, and extension of pituitary macroadenomas into adjacent structures. Materials and methods. The study proposes MRI-based morphological criteria for evaluating pituitary macroadenomas. The analyzed parameters included tumor size, suprasellar and parasellar extension, cavernous sinus invasion, Knosp grade, optic chiasm compression, pituitary stalk deviation, cystic degeneration, necrotic changes, and hemorrhagic components. Results. Functioning and non-functioning pituitary macroadenomas may differ in growth direction and degree of invasiveness. In particular, prolactinomas and somatotropinomas may demonstrate more pronounced lateral invasion into the cavernous sinus, whereas non-functioning macroadenomas more often present with suprasellar extension and optic chiasm compression. Conclusion. MRI-based morphological analysis is important for assessing the biological behavior of pituitary macroadenomas, estimating surgical risk, and individualizing treatment strategy.</p>
      </trans-abstract>
      <trans-abstract xml:lang="ru">
        <p>Актуальность. Макроаденомы гипофиза относятся к числу наиболее значимых объёмных образований селлярно-параселлярной области. Их клиническое течение определяется не только размерами опухоли, но и гормональной активностью, направлением роста, степенью инвазии кавернозного синуса, супраселлярным распространением и взаимоотношением с хиазмой зрительных нервов. Магнитно-резонансная томография является основным методом диагностики, топографо-анатомической оценки и планирования хирургической тактики при макроаденомах гипофиза. Материал и методы. В статье предложен алгоритм МРТ-морфологической оценки макроаденом гипофиза. В качестве критериев анализа рассматривались размеры и объём опухоли, супраселлярное и параселлярное распространение, степень по Knosp, компрессия зрительной хиазмы, девиация ножки гипофиза, наличие некроза, кистозной дегенерации, геморрагических изменений и взаимоотношение со сфеноидальным синусом. Результаты. Функционирующие и нефункционирующие макроаденомы гипофиза могут различаться по направлению роста и степени инвазивности. Пролактиномы и соматотропиномы в ряде случаев характеризуются латеральной инвазией в кавернозный синус, тогда как нефункционирующие макроаденомы чаще проявляются супраселлярным ростом и компрессией зрительной хиазмы. Заключение. МРТ-морфологический анализ имеет важное значение для оценки биологического поведения макроаденом гипофиза, определения операционного риска и индивидуализации лечебной тактики.</p>
      </trans-abstract>
      <kwd-group xml:lang="uz">
        <kwd>gipofiz makroadenomasi</kwd>
        <kwd>PitNET</kwd>
        <kwd>magnit-rezonans tomografiya</kwd>
        <kwd>gormonal faollik</kwd>
        <kwd>prolaktinoma</kwd>
        <kwd>somatotropinoma</kwd>
        <kwd>kavernoz sinus</kwd>
        <kwd>Knosp tasnifi</kwd>
        <kwd>suprasellyar o‘sish</kwd>
        <kwd>optik xiazma</kwd>
      </kwd-group>
      <kwd-group xml:lang="en">
        <kwd>pituitary macroadenoma</kwd>
        <kwd>MRI</kwd>
        <kwd>hormonal activity</kwd>
        <kwd>prolactinoma</kwd>
        <kwd>somatotropinoma</kwd>
        <kwd>cavernous sinus</kwd>
        <kwd>Knosp classification</kwd>
        <kwd>suprasellar growth</kwd>
        <kwd>optic chiasm</kwd>
      </kwd-group>
      <kwd-group xml:lang="ru">
        <kwd>макроаденома гипофиза</kwd>
        <kwd>PitNET</kwd>
        <kwd>магнитно-резонансная томография</kwd>
        <kwd>гормональная активность</kwd>
        <kwd>пролактинома</kwd>
        <kwd>соматотропинома</kwd>
        <kwd>кавернозный синус</kwd>
        <kwd>классификация Knosp</kwd>
        <kwd>супраселлярный рост</kwd>
        <kwd>зрительная хиазма</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <back>
    <ref-list>
      <ref id="r1">
        <label>1</label>
        <mixed-citation>Urmanova, Y. M., Sodikov, S. P., Kim, M., Duschanov, T. A., &amp; Mukhtarova, Sh. Sh. (2019). The frequency and neuroimaging characteristics of macro- and giant pituitary adenomas. International Journal of Biomedicine, 9(1), 72–74. DOI:</mixed-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <mixed-citation>Urmanova, Y. M., Rikhsiyeva, N. T., Tashmanova, A. B., Mirtukhtaeva, M. B., &amp; Urmanova, F. M. (2026). Neuro-imaging characteristics of patients with giant non-functional pituitary adenomas. Biomedical Journal of Scientific &amp; Technical Research, 64(4), 56954–56960. DOI: <pub-id pub-id-type="doi">10.26717/BJSTR.2026.64.010101</pub-id></mixed-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <mixed-citation>Khalimova, Z. Yu., Kholova, D. Sh., Urmanova, Yu. M., Faizullaev, R. B., Alieva, D. A., Alimukhamedova, G. O., Karimova, M. M., &amp; Safarova, Sh. M. (2013). Изучение особенностей семейного наследования неактивных аденом гипофиза в Республике Узбекистан. Международный эндокринологический журнал, 1(49). DOI: <pub-id pub-id-type="doi">10.22141/2224-0721.1.49.2013.84047</pub-id></mixed-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <mixed-citation>Khalimova, Z. Yu., Kholova, D. Sh., Khamedova, F. S., &amp; Alieva, D. A. (2013). Особенности клинического течения и диагностика больных с семейным анамнезом неактивных аденом гипофиза. Международный эндокринологический журнал, 4(52), 28–36.</mixed-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <mixed-citation>Urmanova, Yu. M., &amp; Alimova, K. B. (2016). Нейровизуализационная характеристика гигантских аденом гипофиза в зависимости от механического фактора. Международный эндокринологический журнал, 4, 100–103.</mixed-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <mixed-citation>Urmanova, Yu. M., Shakirova, M. Yu., Rikhsiyeva, N. T., &amp; Khodjaeva, F. S. (2019). Факторы риска рецидива неактивных аденом гипофиза у больных с дефицитом гормона роста. Международный эндокринологический журнал, 15(2), 46–50.</mixed-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <mixed-citation>Urmanova, Yu. M., Khalimova, Z. Yu., &amp; Faizullaev, R. B. (2015). Значение определения клинико-диагностических маркеров агрессивности неактивных аденом гипофиза. Международный эндокринологический журнал, 6(70), 24–27.</mixed-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <mixed-citation>Urmanova, Yu. M., &amp; Alimova, K. B. (2018). Гигантские аденомы гипофиза: распространенность, особенности диагностики и клинического течения. Международный эндокринологический журнал, 14(5), 539–542.</mixed-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <mixed-citation>Faizullaev, R. B. (2009). Гигантские аденомы гипофиза: клиника, диагностика, хирургическое лечение [Докторская диссертация]. Москва.</mixed-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <mixed-citation>Kadashev, B. A. (2007). Аденомы гипофиза: клиника, диагностика, лечение. Тверь.</mixed-citation>
      </ref>
      <ref id="r11">
        <label>11</label>
        <mixed-citation>Kalinin, P. L., Sharipov, O. I., Pronin, I. N., Kutin, M. A., Fomichev, D. V., Kadashev, B. A., Shkarubo, A. N., Alekseev, S. N., Astaf’eva, L. I., Tropinskaya, O. F., Dobrovolskiy, G. F., Shults, E. I., Andreev, D. N., Voronina, I. A., &amp; Kurnosov, A. B. (2016). Endoscopic transsphenoidal resection of pituitary adenomas invading the cavernous sinus. Burdenko’s Journal of Neurosurgery, 80(4), 63–74. DOI: <pub-id pub-id-type="doi">10.17116/neiro201680463-74</pub-id></mixed-citation>
      </ref>
      <ref id="r12">
        <label>12</label>
        <mixed-citation>Kalinin, P. L., Kadashev, B. A., Fomichev, D. V., Kutin, M. A., Astaf’eva, L. I., Sharipov, O. I., Shkarubo, A. N., Tropinskaya, O. F., Voronina, I. A., &amp; Fomochkina, L. A. (2017). Surgical treatment for pituitary adenomas. Burdenko’s Journal of Neurosurgery, 81(1), 95–</mixed-citation>
      </ref>
      <ref id="r13">
        <label>13</label>
        <mixed-citation>DOI: <pub-id pub-id-type="doi">10.17116/neiro201780795-107</pub-id></mixed-citation>
      </ref>
      <ref id="r14">
        <label>14</label>
        <mixed-citation>Eremkina, A. K., Dzeranova, L. K., Pigarova, E. K., Mokrysheva, N. G., &amp; Dedov, I. I. (2019). Morphofunctional features of non- functioning pituitary adenomas. Russian Journal of Archive of Pathology, 81(1), 71–78. DOI: <pub-id pub-id-type="doi">10.17116/patol20198101171</pub-id></mixed-citation>
      </ref>
      <ref id="r15">
        <label>15</label>
        <mixed-citation>Fedorova, N. S., Abrosimov, A. Iu., Dzeranova, L. K., Pigarova, E. A., &amp; Dedov, I. I. (2018). Pituitary lactotroph adenomas resistant to dopamine agonist treatment: Histological and immunohistochemical characteristics. Russian Journal of Archive of Pathology, 80(3), 34–39. DOI: <pub-id pub-id-type="doi">10.17116/patol201880334-39</pub-id></mixed-citation>
      </ref>
      <ref id="r16">
        <label>16</label>
        <mixed-citation>Ilovayskaya, I. A., Dreval, A. V., Krivosheeva, Yu. G., et al. (2016). Особенности роста макроаденом гипофиза с различной гормональной активностью. Альманах клинической медицины, 44(4), 451–456.</mixed-citation>
      </ref>
      <ref id="r17">
        <label>17</label>
        <mixed-citation>Astaf’eva, L. I., Kadashev, B. A., &amp; Kalinin, P. L. (2017). Развитие назальной ликвореи у молодой женщины с гигантской пролактиномой через 6,5 лет терапии каберголином. Эндокринная хирургия, 11(4), 201–208.</mixed-citation>
      </ref>
      <ref id="r18">
        <label>18</label>
        <mixed-citation>Astaf’eva, L. I., Kalinin, P. L., Kadashev, B. A., et al. (2009). Выбор тактики лечения гигантских пролактинсекретирующих аденом гипофиза. Вопросы нейрохирургии имени Н. Н. Бурденко, 2, 23–</mixed-citation>
      </ref>
      <ref id="r19">
        <label>19</label>
        <mixed-citation>Kadashev, B. A., Kutin, M. A., Kalinin, P. L., Trunin, Yu. K., Alekseev, S. N., &amp; Shkarubo, A. N. (2004). Сравнительная оценка результатов хирургического лечения пациентов с аденомами гипофиза, инфильтрирующими кавернозный синус. Вопросы нейрохирургии имени Н. Н. Бурденко, 3, 14–17.</mixed-citation>
      </ref>
      <ref id="r20">
        <label>20</label>
        <mixed-citation>Shkarubo, A. N., Shishkina, L. V., Serova, N. K., et al. (2015). Эндоскопическое эндоназальное удаление крупной аденомы гипофиза, распространяющейся в заднюю черепную ямку. Вопросы нейрохирургии имени Н. Н. Бурденко, 79(6), 85–91.</mixed-citation>
      </ref>
      <ref id="r21">
        <label>21</label>
        <mixed-citation>Kalinin, P. L., Shkarubo, A. N., Astaf’eva, L. I., et al. (2017). Назальная ликворея при первичном лечении больших и гигантских пролактином агонистами дофамина. Вопросы нейрохирургии имени Н. Н. Бурденко, 81(6), 32–39.</mixed-citation>
      </ref>
      <ref id="r22">
        <label>22</label>
        <mixed-citation>Asa, S. L., Mete, O., Perry, A., &amp; Osamura, R. Y. (2022). Overview of the 2022 WHO classification of pituitary tumors. Endocrine Pathology, 33, 6–26. DOI: <pub-id pub-id-type="doi">10.1007/s12022-022-09703-7</pub-id></mixed-citation>
      </ref>
      <ref id="r23">
        <label>23</label>
        <mixed-citation>Casar-Borota, O., Asioli, S., &amp; Mete, O. (2024). The 2022 WHO classification of tumors of the pituitary gland. Brain Pathology, 34, e13302. DOI: <pub-id pub-id-type="doi">10.1111/bpa.13302</pub-id></mixed-citation>
      </ref>
      <ref id="r24">
        <label>24</label>
        <mixed-citation>Tsukamoto, T., Miki, Y., &amp; Takahashi, J. A. (2023). Imaging of pituitary tumors: An update with the 5th WHO classification. Japanese Journal of Radiology, 41, 789–806. DOI: 10.1007/s11604-023-01402- 9 <pub-id pub-id-type="doi">10.1007/s11604-023-01402-9</pub-id></mixed-citation>
      </ref>
      <ref id="r25">
        <label>25</label>
        <mixed-citation>Knosp, E., Steiner, E., Kitz, K., &amp; Matula, C. (1993). Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery, 33(4), 610–618. DOI: 10.1227/00006123-199310000- 00008 <pub-id pub-id-type="doi">10.1227/00006123-199310000-00008</pub-id></mixed-citation>
      </ref>
      <ref id="r26">
        <label>26</label>
        <mixed-citation>Cottier, J. P., Destrieux, C., Brunereau, L., Bertrand, P., Moreau, L., Jan, M., &amp; Herbreteau, D. (2000). Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology, 215(2), 463–469. DOI:</mixed-citation>
      </ref>
      <ref id="r27">
        <label>27</label>
        <mixed-citation>1148/radiology.215.2.r00ap18463</mixed-citation>
      </ref>
      <ref id="r28">
        <label>28</label>
        <mixed-citation>Micko, A. S. G., Wöhrer, A., Wolfsberger, S., &amp; Knosp, E. (2015). Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification. Journal of Neurosurgery, 122(4), 803–811. DOI:</mixed-citation>
      </ref>
      <ref id="r29">
        <label>29</label>
        <mixed-citation>Serioli, S., Doglietto, F., Fiorindi, A., Biroli, A., Mattavelli, D., Buffoli, B., &amp; Fontanella, M. M. (2019). Pituitary adenomas and invasiveness from anatomo-surgical, radiological, and histological perspectives: A systematic literature review. Cancers, 11(12), 1936. DOI: <pub-id pub-id-type="doi">10.3390/cancers11121936</pub-id></mixed-citation>
      </ref>
      <ref id="r30">
        <label>30</label>
        <mixed-citation>Pereira, F. V., Chaddad Neto, F., &amp; colleagues. (2025). Pituitary macroadenoma: Less common neuroimaging features in a common lesion. Radiologia Brasileira, 58, e20240048.</mixed-citation>
      </ref>
      <ref id="r31">
        <label>31</label>
        <mixed-citation>Eisenhut, F., Schlaffer, S. M., Hirt, B., et al. (2022). Improved detection of cavernous sinus invasion of pituitary macroadenomas with ultra-high-field 7 T MRI. Cancers, 14(1), 162. DOI:</mixed-citation>
      </ref>
      <ref id="r32">
        <label>32</label>
        <mixed-citation>Gruppetta, M., &amp; Vassallo, J. (2016). Epidemiology and radiological geometric assessment of pituitary macroadenomas: Population-based study. Clinical Endocrinology, 85(2), 223–231. DOI:</mixed-citation>
      </ref>
      <ref id="r33">
        <label>33</label>
        <mixed-citation>Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., &amp; Vance, M. L. (2011). Pituitary incidentaloma: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology &amp; Metabolism, 96(4), 894–904. DOI: 10.1210/jc.2010- 1048 <pub-id pub-id-type="doi">10.1210/jc.2010-1048</pub-id></mixed-citation>
      </ref>
      <ref id="r34">
        <label>34</label>
        <mixed-citation>Petersenn, S., Fleseriu, M., Casanueva, F. F., et al. (2023). Diagnosis and management of prolactin-secreting pituitary adenomas: A Pituitary Society international consensus statement. Nature Reviews Endocrinology, 19, 722–740. DOI: <pub-id pub-id-type="doi">10.1038/s41574-023-00886-5</pub-id></mixed-citation>
      </ref>
      <ref id="r35">
        <label>35</label>
        <mixed-citation>Fleseriu, M., Biller, B. M. K., Freda, P. U., et al. (2021). A Pituitary Society update to acromegaly management guidelines. Pituitary, 24, 1–13. DOI: <pub-id pub-id-type="doi">10.1007/s11102-020-01091-7</pub-id></mixed-citation>
      </ref>
      <ref id="r36">
        <label>36</label>
        <mixed-citation>Drummond, J. B., Ribeiro-Oliveira, A., &amp; Soares, B. S. (2022). Non- functioning pituitary adenomas. In K. R. Feingold, B. Anawalt, M. R. Blackman, et al. (Eds.), Endotext. MDText.com.</mixed-citation>
      </ref>
      <ref id="r37">
        <label>37</label>
        <mixed-citation>Molitch, M. E. (2017). Diagnosis and treatment of pituitary adenomas: A review. JAMA, 317(5), 516–524. DOI: <pub-id pub-id-type="doi">10.1001/jama.2016.19699</pub-id></mixed-citation>
      </ref>
      <ref id="r38">
        <label>38</label>
        <mixed-citation>Urmanova, Y. M., Sodikov, S. P., Kim, M., Duschanov, T. A., &amp; Mukhtarova, Sh. Sh. (2019). The frequency and neuroimaging characteristics of macro- and giant pituitary adenomas. International Journal of Biomedicine, 9(1), 72–74. DOI:</mixed-citation>
      </ref>
      <ref id="r39">
        <label>39</label>
        <mixed-citation>Urmanova, Y. M., Rikhsiyeva, N. T., Tashmanova, A. B., Mirtukhtaeva, M. B., &amp; Urmanova, F. M. (2026). Neuro-imaging characteristics of patients with giant non-functional pituitary adenomas. Biomedical Journal of Scientific &amp; Technical Research, 64(4), 56954–56960. DOI: <pub-id pub-id-type="doi">10.26717/BJSTR.2026.64.010101</pub-id></mixed-citation>
      </ref>
      <ref id="r40">
        <label>40</label>
        <mixed-citation>Khalimova, Z. Yu., Kholova, D. Sh., Urmanova, Yu. M., Faizullaev, R. B., Alieva, D. A., Alimukhamedova, G. O., Karimova, M. M., &amp; Safarova, Sh. M. (2013). Izuchenie osobennostey semeynogo nasledovaniya neaktivnykh adenom gipofiza v Respublike Uzbekistan [Study of the features of familial inheritance of non-functioning pituitary adenomas in the Republic of Uzbekistan]. Mezhdunarodnyy endokrinologicheskiy zhurnal, 1(49). DOI: 10.22141/2224- 0721.1.49.2013.84047 (in Russian) <pub-id pub-id-type="doi">10.22141/2224-0721.1.49.2013.84047</pub-id></mixed-citation>
      </ref>
      <ref id="r41">
        <label>41</label>
        <mixed-citation>Khalimova, Z. Yu., Kholova, D. Sh., Khamedova, F. S., &amp; Alieva, D. A. (2013). Osobennosti klinicheskogo techeniya i diagnostika bol&apos;nykh s semeynym anamnezom neaktivnykh adenom gipofiza [Clinical course and diagnosis in patients with a family history of non- functioning pituitary adenomas]. Mezhdunarodnyy endokrinologicheskiy zhurnal, 4(52), 28–36. (in Russian)</mixed-citation>
      </ref>
      <ref id="r42">
        <label>42</label>
        <mixed-citation>Urmanova, Yu. M., &amp; Alimova, K. B. (2016). Neyrovizualizatsionnaya kharakteristika gigantskikh adenom gipofiza v zavisimosti ot mekhanicheskogo faktora [Neuroimaging characteristics of giant pituitary adenomas depending on the mechanical factor]. Mezhdunarodnyy endokrinologicheskiy zhurnal, 4, 100–103. (in Russian)</mixed-citation>
      </ref>
      <ref id="r43">
        <label>43</label>
        <mixed-citation>Urmanova, Yu. M., Shakirova, M. Yu., Rikhsiyeva, N. T., &amp; Khodjaeva, F. S. (2019). Faktory riska retsidiva neaktivnykh adenom gipofiza u bol&apos;nykh s defitsitom gormona rosta [Risk factors for recurrence of non-functioning pituitary adenomas in patients with growth hormone deficiency]. Mezhdunarodnyy endokrinologicheskiy zhurnal, 15(2), 46–50. (in Russian)</mixed-citation>
      </ref>
      <ref id="r44">
        <label>44</label>
        <mixed-citation>Urmanova, Yu. M., Khalimova, Z. Yu., &amp; Faizullaev, R. B. (2015). Znachenie opredeleniya kliniko-diagnosticheskikh markerov agressivnosti neaktivnykh adenom gipofiza [Significance of determining clinical and diagnostic markers of aggressiveness of non- functioning pituitary adenomas]. Mezhdunarodnyy endokrinologicheskiy zhurnal, 6(70), 24–27. (in Russian)</mixed-citation>
      </ref>
      <ref id="r45">
        <label>45</label>
        <mixed-citation>Urmanova, Yu. M., &amp; Alimova, K. B. (2018). Gigantskie adenomy gipofiza: rasprostranennost&apos;, osobennosti diagnostiki i klinicheskogo techeniya [Giant pituitary adenomas: prevalence, diagnostic features and clinical course]. Mezhdunarodnyy endokrinologicheskiy zhurnal, 14(5), 539–542. (in Russian)</mixed-citation>
      </ref>
      <ref id="r46">
        <label>46</label>
        <mixed-citation>Faizullaev, R. B. (2009). Gigantskie adenomy gipofiza: klinika, diagnostika, khirurgicheskoe lechenie [Giant pituitary adenomas: clinical picture, diagnosis, surgical treatment] [Doctoral dissertation]. Moskva. (in Russian)</mixed-citation>
      </ref>
      <ref id="r47">
        <label>47</label>
        <mixed-citation>Kadashev, B. A. (2007). Adenomy gipofiza: klinika, diagnostika, lechenie [Pituitary adenomas: clinical picture, diagnosis, treatment]. Tver&apos;. (in Russian)</mixed-citation>
      </ref>
      <ref id="r48">
        <label>48</label>
        <mixed-citation>Kalinin, P. L., Sharipov, O. I., Pronin, I. N., Kutin, M. A., Fomichev, D. V., Kadashev, B. A., Shkarubo, A. N., Alekseev, S. N., Astaf’eva, L. I., Tropinskaya, O. F., Dobrovolskiy, G. F., Shults, E. I., Andreev, D. N., Voronina, I. A., &amp; Kurnosov, A. B. (2016). Endoscopic transsphenoidal resection of pituitary adenomas invading the cavernous sinus. Burdenko’s Journal of Neurosurgery, 80(4), 63–74. DOI: <pub-id pub-id-type="doi">10.17116/neiro201680463-74</pub-id></mixed-citation>
      </ref>
      <ref id="r49">
        <label>49</label>
        <mixed-citation>Kalinin, P. L., Kadashev, B. A., Fomichev, D. V., Kutin, M. A., Astaf’eva, L. I., Sharipov, O. I., Shkarubo, A. N., Tropinskaya, O. F., Voronina, I. A., &amp; Fomochkina, L. A. (2017). Surgical treatment for pituitary adenomas. Burdenko’s Journal of Neurosurgery, 81(1), 95–</mixed-citation>
      </ref>
      <ref id="r50">
        <label>50</label>
        <mixed-citation>DOI: <pub-id pub-id-type="doi">10.17116/neiro201780795-107</pub-id></mixed-citation>
      </ref>
      <ref id="r51">
        <label>51</label>
        <mixed-citation>Eremkina, A. K., Dzeranova, L. K., Pigarova, E. K., Mokrysheva, N. G., &amp; Dedov, I. I. (2019). Morphofunctional features of non- functioning pituitary adenomas. Russian Journal of Archive of Pathology, 81(1), 71–78. DOI: <pub-id pub-id-type="doi">10.17116/patol20198101171</pub-id></mixed-citation>
      </ref>
      <ref id="r52">
        <label>52</label>
        <mixed-citation>Fedorova, N. S., Abrosimov, A. Iu., Dzeranova, L. K., Pigarova, E. A., &amp; Dedov, I. I. (2018). Pituitary lactotroph adenomas resistant to dopamine agonist treatment: Histological and immunohistochemical characteristics. Russian Journal of Archive of Pathology, 80(3), 34–39. DOI: <pub-id pub-id-type="doi">10.17116/patol201880334-39</pub-id></mixed-citation>
      </ref>
      <ref id="r53">
        <label>53</label>
        <mixed-citation>Ilovayskaya, I. A., Dreval, A. V., Krivosheeva, Yu. G., et al. (2016). Osobennosti rosta makroadenom gipofiza s razlichnoy gormonal&apos;noy aktivnost&apos;yu [Growth features of pituitary macroadenomas with different hormonal activity]. Al&apos;manakh klinicheskoy meditsiny, 44(4), 451–456. (in Russian)</mixed-citation>
      </ref>
      <ref id="r54">
        <label>54</label>
        <mixed-citation>Astaf’eva, L. I., Kadashev, B. A., &amp; Kalinin, P. L. (2017). Razvitie nazal&apos;noy likvorei u molodoy zhenshchiny s gigantskoy prolaktinomoy cherez 6,5 let terapii kabergolinom [Development of nasal liquorrhea in a young woman with a giant prolactinoma after 6.5 years of cabergoline therapy]. Endokrinnaya khirurgiya, 11(4), 201–208. (in Russian)</mixed-citation>
      </ref>
      <ref id="r55">
        <label>55</label>
        <mixed-citation>Astaf’eva, L. I., Kalinin, P. L., Kadashev, B. A., et al. (2009). Vybor taktiki lecheniya gigantskikh prolaktinsekretiruyushchikh adenom gipofiza [Choice of treatment strategy for giant prolactin-secreting pituitary adenomas]. Voprosy neyrokhirurgii imeni N. N. Burdenko, 2, 23–29. (in Russian)</mixed-citation>
      </ref>
      <ref id="r56">
        <label>56</label>
        <mixed-citation>Kadashev, B. A., Kutin, M. A., Kalinin, P. L., Trunin, Yu. K., Alekseev, S. N., &amp; Shkarubo, A. N. (2004). Sravnitel&apos;naya otsenka rezul&apos;tatov khirurgicheskogo lecheniya patsientov s adenomami gipofiza, infil&apos;triruyushchimi kavernoznyy sinus [Comparative evaluation of the results of surgical treatment of patients with pituitary adenomas infiltrating the cavernous sinus]. Voprosy neyrokhirurgii imeni N. N. Burdenko, 3, 14–17. (in Russian)</mixed-citation>
      </ref>
      <ref id="r57">
        <label>57</label>
        <mixed-citation>Shkarubo, A. N., Shishkina, L. V., Serova, N. K., et al. (2015). Endoskopicheskoe endonazal&apos;noe udalenie krupnoy adenomy gipofiza, rasprostranyayushcheysya v zadnyuyu cherepnuyu yamku [Endoscopic endonasal removal of a large pituitary adenoma extending into the posterior cranial fossa]. Voprosy neyrokhirurgii imeni N. N. Burdenko, 79(6), 85–91. (in Russian)</mixed-citation>
      </ref>
      <ref id="r58">
        <label>58</label>
        <mixed-citation>Kalinin, P. L., Shkarubo, A. N., Astaf’eva, L. I., et al. (2017). Nazal&apos;naya likvoreya pri pervichnom lechenii bol&apos;shikh i gigantskikh prolaktinom agonistami dofamina [Nasal liquorrhea during primary treatment of large and giant prolactinomas with dopamine agonists]. Voprosy neyrokhirurgii imeni N. N. Burdenko, 81(6), 32–39. (in Russian)</mixed-citation>
      </ref>
      <ref id="r59">
        <label>59</label>
        <mixed-citation>Asa, S. L., Mete, O., Perry, A., &amp; Osamura, R. Y. (2022). Overview of the 2022 WHO classification of pituitary tumors. Endocrine Pathology, 33, 6–26. DOI: <pub-id pub-id-type="doi">10.1007/s12022-022-09703-7</pub-id></mixed-citation>
      </ref>
      <ref id="r60">
        <label>60</label>
        <mixed-citation>Casar-Borota, O., Asioli, S., &amp; Mete, O. (2024). The 2022 WHO classification of tumors of the pituitary gland. Brain Pathology, 34, e13302. DOI: <pub-id pub-id-type="doi">10.1111/bpa.13302</pub-id></mixed-citation>
      </ref>
      <ref id="r61">
        <label>61</label>
        <mixed-citation>Tsukamoto, T., Miki, Y., &amp; Takahashi, J. A. (2023). Imaging of pituitary tumors: An update with the 5th WHO classification. Japanese Journal of Radiology, 41, 789–806. DOI: 10.1007/s11604-023-01402- 9 <pub-id pub-id-type="doi">10.1007/s11604-023-01402-9</pub-id></mixed-citation>
      </ref>
      <ref id="r62">
        <label>62</label>
        <mixed-citation>Knosp, E., Steiner, E., Kitz, K., &amp; Matula, C. (1993). Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery, 33(4), 610–618. DOI: 10.1227/00006123-199310000- 00008 <pub-id pub-id-type="doi">10.1227/00006123-199310000-00008</pub-id></mixed-citation>
      </ref>
      <ref id="r63">
        <label>63</label>
        <mixed-citation>Cottier, J. P., Destrieux, C., Brunereau, L., Bertrand, P., Moreau, L., Jan, M., &amp; Herbreteau, D. (2000). Cavernous sinus invasion by pituitary adenoma: MR imaging. Radiology, 215(2), 463–469. DOI:</mixed-citation>
      </ref>
      <ref id="r64">
        <label>64</label>
        <mixed-citation>1148/radiology.215.2.r00ap18463</mixed-citation>
      </ref>
      <ref id="r65">
        <label>65</label>
        <mixed-citation>Micko, A. S. G., Wöhrer, A., Wolfsberger, S., &amp; Knosp, E. (2015). Invasion of the cavernous sinus space in pituitary adenomas: Endoscopic verification and its correlation with an MRI-based classification. Journal of Neurosurgery, 122(4), 803–811. DOI:</mixed-citation>
      </ref>
      <ref id="r66">
        <label>66</label>
        <mixed-citation>Serioli, S., Doglietto, F., Fiorindi, A., Biroli, A., Mattavelli, D., Buffoli, B., &amp; Fontanella, M. M. (2019). Pituitary adenomas and invasiveness from anatomo-surgical, radiological, and histological perspectives: A systematic literature review. Cancers, 11(12), 1936. DOI: <pub-id pub-id-type="doi">10.3390/cancers11121936</pub-id></mixed-citation>
      </ref>
      <ref id="r67">
        <label>67</label>
        <mixed-citation>Pereira, F. V., Chaddad Neto, F., &amp; colleagues. (2025). Pituitary macroadenoma: Less common neuroimaging features in a common lesion. Radiologia Brasileira, 58, e20240048.</mixed-citation>
      </ref>
      <ref id="r68">
        <label>68</label>
        <mixed-citation>Eisenhut, F., Schlaffer, S. M., Hirt, B., et al. (2022). Improved detection of cavernous sinus invasion of pituitary macroadenomas with ultra-high-field 7 T MRI. Cancers, 14(1), 162. DOI:</mixed-citation>
      </ref>
      <ref id="r69">
        <label>69</label>
        <mixed-citation>Gruppetta, M., &amp; Vassallo, J. (2016). Epidemiology and radiological geometric assessment of pituitary macroadenomas: Population-based study. Clinical Endocrinology, 85(2), 223–231. DOI:</mixed-citation>
      </ref>
      <ref id="r70">
        <label>70</label>
        <mixed-citation>Freda, P. U., Beckers, A. M., Katznelson, L., Molitch, M. E., Montori, V. M., Post, K. D., &amp; Vance, M. L. (2011). Pituitary incidentaloma: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology &amp; Metabolism, 96(4), 894–904. DOI: <pub-id pub-id-type="doi">10.1210/jc.2010-</pub-id></mixed-citation>
      </ref>
      <ref id="r71">
        <label>71</label>
        <mixed-citation>Petersenn, S., Fleseriu, M., Casanueva, F. F., et al. (2023). Diagnosis and management of prolactin-secreting pituitary adenomas: A Pituitary Society international consensus statement. Nature Reviews Endocrinology, 19, 722–740. DOI: <pub-id pub-id-type="doi">10.1038/s41574-023-00886-5</pub-id></mixed-citation>
      </ref>
      <ref id="r72">
        <label>72</label>
        <mixed-citation>Fleseriu, M., Biller, B. M. K., Freda, P. U., et al. (2021). A Pituitary Society update to acromegaly management guidelines. Pituitary, 24, 1–13. DOI: <pub-id pub-id-type="doi">10.1007/s11102-020-01091-7</pub-id></mixed-citation>
      </ref>
      <ref id="r73">
        <label>73</label>
        <mixed-citation>Drummond, J. B., Ribeiro-Oliveira, A., &amp; Soares, B. S. (2022). Non- functioning pituitary adenomas. In K. R. Feingold, B. Anawalt, M. R. Blackman, et al. (Eds.), Endotext. MDText.com.</mixed-citation>
      </ref>
      <ref id="r74">
        <label>74</label>
        <mixed-citation>Molitch, M. E. (2017). Diagnosis and treatment of pituitary adenomas: A review. JAMA, 317(5), 516–524. DOI: <pub-id pub-id-type="doi">10.1001/jama.2016.19699</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
